
    
      This study is a non-randomized, uncontrolled feasibility study that looks to enroll people
      with type 1 diabetes who are currently using an insulin pump. During the subject's
      participation, the study staff will closely monitor the study subject in a clinical research
      center environment for approximately 24 hours, while controller algorithm determined insulin
      doses are delivered by an insulin pump, and utilizing continuous glucose monitoring results.

      Total subject participation approximately 1 week for screening to completion. This includes
      approximately 24 hours usage of the investigation device in the clinical research center
      under close medical supervision.
    
  